Pilatus Biosciences Announces First Patient Dosed in Hong Kong Clinical Trial of PLT012 for Liver Cancer Expansion
Pilatus Biosciences Announces First Patient Dosed in Hong Kong Clinical Trial of PLT012 for Liver Cancer Expansion Yahoo Finance
1636 материалов по теме, собраны автоматически из проверенных источников
Pilatus Biosciences Announces First Patient Dosed in Hong Kong Clinical Trial of PLT012 for Liver Cancer Expansion Yahoo Finance
Letter From the Co-Chairs, October 2026 ECOG-ACRIN Cancer Research Group
Trial Results: ECOG-ACRIN Research Round-Up ECOG-ACRIN Cancer Research Group
News in Brief, October 2026 ECOG-ACRIN Cancer Research Group
A landscape assessment of more than 150 studies revealed reductions in circulating tumor DNA are associated with improved OS across solid cancer types, despite substantial heterogeneity in assays and collection and sampling timepoints. “There’s a remarkably consistent signal across a diverse body of research,” Elena…
Michelle Mitchell: Accelerating Progress in Cancer Research for Children and Young People Oncodaily
Trials to watch: First cancer vaccine success could trigger a domino effect Clinical Trials Arena
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial Nature
Amanda Pullinger: How Can Networking and Mentorship Advance the Next Generation of Cancer Researchers? Oncodaily
Gale and Ira Drukier Prize in Children’s Health Research Awarded to Harvard Pediatric Hematologist-Oncologist WCM Newsroom
ArriVent doses first patient with ARR-002 dual-target ADC for ovarian cancer The Clinical Trial Vanguard
Contrary to popular belief, the postmenopausal ovary is not defunct. In a new study of ovaries from 28 women, scientists at Northwestern University and the Buck Institute for Research on Aging found that in the decades well past menopause, the ovary remains biologically active and continues to remodel with age…
University of Arizona mourns cancer researcher Dr. Rachna Shroff Diya TV
Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) show a possible way to improve therapy options for patients with relapsed or treatment-resistant B-cell blood cancers. The findings…
IARC Director Elisabete Weiderpass to Discuss How to Turn Cancer Research Into Action at Momentum 2026 Oncodaily